AAAAAA

   
Results: 1-17 |
Results: 17
DOES SEVERITY OF ISCHEMIC CORONARY-DISEASE CORRELATE WITH ERECTILE FUNCTION
Authors: SULLIVAN ME MILLER MAW BELL CRW JAGROOP IA THOMPSON CS WINDER AP MORGAN RJ MIKHAILIDIS DP
Citation: Me. Sullivan et al., DOES SEVERITY OF ISCHEMIC CORONARY-DISEASE CORRELATE WITH ERECTILE FUNCTION, International journal of impotence research, 10(2), 1998, pp. 75-75
DANAPAROID - AN ANTITHROMBOTIC AGENT WITHOUT MAJOR IMPACT ON TRIGLYCERIDE HYDROLYSIS CAPACITY IN HUMANS
Authors: MIKHAILIDIS DP JAGROOP IA
Citation: Dp. Mikhailidis et Ia. Jagroop, DANAPAROID - AN ANTITHROMBOTIC AGENT WITHOUT MAJOR IMPACT ON TRIGLYCERIDE HYDROLYSIS CAPACITY IN HUMANS, Journal of internal medicine, 244(2), 1998, pp. 184-184
IS CLOPIDOGREL MARKEDLY SUPERIOR TO ASPIRIN IN PATIENTS WITH PERIPHERAL VASCULAR-DISEASE
Authors: MIKHAILIDIS DP JAGROOP IA
Citation: Dp. Mikhailidis et Ia. Jagroop, IS CLOPIDOGREL MARKEDLY SUPERIOR TO ASPIRIN IN PATIENTS WITH PERIPHERAL VASCULAR-DISEASE, Platelets, 9(5), 1998, pp. 273-278
ANPLAG, A SELECTIVE 5-HT2 RECEPTOR ANTAGONIST, REDUCES STENOSIS INDUCED BY BALLOON INJURY IN HYPERCHOLESTEROLEMIC RABBIT
Authors: JAGROOP IA MIKHALILDIS DP
Citation: Ia. Jagroop et Dp. Mikhalildis, ANPLAG, A SELECTIVE 5-HT2 RECEPTOR ANTAGONIST, REDUCES STENOSIS INDUCED BY BALLOON INJURY IN HYPERCHOLESTEROLEMIC RABBIT, International angiology, 17(1), 1998, pp. 62-62
STATINS AND FIBRINOGEN
Authors: NAIR DR PAPADAKIS JA JAGROOP IA MIKHAILIDIS DP WINDER AF
Citation: Dr. Nair et al., STATINS AND FIBRINOGEN, Lancet, 351(9113), 1998, pp. 1430-1430
ERYTHROCYTE PROMOTION OF PLATELET REACTIVITY DECREASES THE EFFECTIVENESS OF ASPIRIN AS AN ANTITHROMBOTIC THERAPEUTIC MODALITY
Authors: JAGROOP IA MIKHAILIDIS DP
Citation: Ia. Jagroop et Dp. Mikhailidis, ERYTHROCYTE PROMOTION OF PLATELET REACTIVITY DECREASES THE EFFECTIVENESS OF ASPIRIN AS AN ANTITHROMBOTIC THERAPEUTIC MODALITY, Circulation, 98(17), 1998, pp. 1826-1826
PATHOPHYSIOLOGY OF HEPARIN-INDUCED THROMBOCYTOPENIA (HIT)
Authors: MIKHAILIDIS DP JAGROOP IA GANOTAKIS ES
Citation: Dp. Mikhailidis et al., PATHOPHYSIOLOGY OF HEPARIN-INDUCED THROMBOCYTOPENIA (HIT), Platelets, 8(1), 1997, pp. 66-68
THE PARACRINE ENDOTHELIN SYSTEM - PATHOPHYSIOLOGY AND IMPLICATIONS INCLINICAL MEDICINE
Authors: DASHWOOD MR MUMTAZ FH SULLIVAN ME JAGROOP IA THOMPSON CS MORGAN RJ MIKHAILIDIS DP
Citation: Mr. Dashwood et al., THE PARACRINE ENDOTHELIN SYSTEM - PATHOPHYSIOLOGY AND IMPLICATIONS INCLINICAL MEDICINE, European journal of clinical chemistry and clinical biochemistry, 35(8), 1997, pp. 645-646
PRELIMINARY-REPORT - CIPROFIBRATE-FLUVASTATIN COMBINATION THERAPY FORDYSLIPIDEMIA
Authors: GANOTAKIS ES JAGROOP IA HAMILTON G WINDER AF MIKHAILIDIS DP
Citation: Es. Ganotakis et al., PRELIMINARY-REPORT - CIPROFIBRATE-FLUVASTATIN COMBINATION THERAPY FORDYSLIPIDEMIA, Journal of drug development and clinical practice, 8(3), 1996, pp. 171-175
UNTITLED
Authors: JAGROOP IA MIKHAILIDIS DP
Citation: Ia. Jagroop et Dp. Mikhailidis, UNTITLED, Journal of drug development and clinical practice, 8(1), 1996, pp. 53-54
THE ACUTE RISE IN PLASMA-FIBRINOGEN CONCENTRATION WITH EXERCISE IS INFLUENCED BY THE G-(453)-A POLYMORPHISM OF THE BETA-FIBRINOGEN GENE
Authors: MONTGOMERY HE CLARKSON P NWOSE OM MIKAILIDIS DP JAGROOP IA DOLLERY G MOULT J BENHIZIA F DEANFIELD J JUBB M WORLD M MCEWAN JR WINDER A HUMPHRIES S
Citation: He. Montgomery et al., THE ACUTE RISE IN PLASMA-FIBRINOGEN CONCENTRATION WITH EXERCISE IS INFLUENCED BY THE G-(453)-A POLYMORPHISM OF THE BETA-FIBRINOGEN GENE, Arteriosclerosis, thrombosis, and vascular biology, 16(3), 1996, pp. 386-391
A LOW-MOLECULAR-WEIGHT HEPARIN, NADROPARIN, (FRAXIPARINE), INHIBITS THROMBIN-INDUCED PLATELET SHAPE CHANGE AND DOES NOT ENHANCE SPONTANEOUSPLATELET-AGGREGATION (VOL 41, PG 163, 1996)
Authors: JAGROOP IA BARRADAS MA MIKHAILIDIS D
Citation: Ia. Jagroop et al., A LOW-MOLECULAR-WEIGHT HEPARIN, NADROPARIN, (FRAXIPARINE), INHIBITS THROMBIN-INDUCED PLATELET SHAPE CHANGE AND DOES NOT ENHANCE SPONTANEOUSPLATELET-AGGREGATION (VOL 41, PG 163, 1996), British journal of clinical pharmacology, 42(4), 1996, pp. 1-1
A LOW-MOLECULAR-WEIGHT HEPARIN, NADROPARIN (FRAXIPARINE), INHIBITS THROMBIN-INDUCED PLATELET SHAPE CHANGE AND DOES NOT ENHANCE SPONTANEOUS PLATELET-AGGREGATION
Authors: JAGROOP IA BARRADAS MA MIKHAILIDIS DP
Citation: Ia. Jagroop et al., A LOW-MOLECULAR-WEIGHT HEPARIN, NADROPARIN (FRAXIPARINE), INHIBITS THROMBIN-INDUCED PLATELET SHAPE CHANGE AND DOES NOT ENHANCE SPONTANEOUS PLATELET-AGGREGATION, British journal of clinical pharmacology, 41(2), 1996, pp. 163-165
BENEFICIAL-EFFECTS OF STATINS
Authors: MIKHAILIDIS DP GANOTAKIS ES JAGROOP IA WINDER AF
Citation: Dp. Mikhailidis et al., BENEFICIAL-EFFECTS OF STATINS, Lancet, 348(9041), 1996, pp. 1582-1583
LOW-MOLECULAR-WEIGHT HEPARIN DURING INSTABILITY IN CORONARY-ARTERY DISEASE
Authors: MIKHAILIDIS DP JAGROOP IA GANOTAKIS E KNIGHT CJ GOODALL AH
Citation: Dp. Mikhailidis et al., LOW-MOLECULAR-WEIGHT HEPARIN DURING INSTABILITY IN CORONARY-ARTERY DISEASE, Lancet, 347(9009), 1996, pp. 1191-1191
CORRELATIONS BETWEEN PLATELET-AGGREGATION, FIBRINOLYSIS, PERIPHERAL AND CENTRAL SEROTONERGIC MEASURES IN SUBHUMAN PRIMATES
Authors: MIKHAILIDIS DP JAGROOP IA BARRADAS MA WINDER AF
Citation: Dp. Mikhailidis et al., CORRELATIONS BETWEEN PLATELET-AGGREGATION, FIBRINOLYSIS, PERIPHERAL AND CENTRAL SEROTONERGIC MEASURES IN SUBHUMAN PRIMATES, Atherosclerosis, 113(1), 1995, pp. 135-135
NAFTIDROFURYL INHIBITS THE RELEASE OF 5-HYDROXYTRYPTAMINE AND PLATELET-DERIVED GROWTH-FACTOR FROM HUMAN PLATELETS
Authors: BARRADAS MA JAGROOP IA MIKHAILIDIS DP
Citation: Ma. Barradas et al., NAFTIDROFURYL INHIBITS THE RELEASE OF 5-HYDROXYTRYPTAMINE AND PLATELET-DERIVED GROWTH-FACTOR FROM HUMAN PLATELETS, Clinica chimica acta, 230(2), 1994, pp. 157-167
Risultati: 1-17 |